Integrated Filing — IndAS



General information about company

Scrip Code 532843
NSE Symbol FORTIS
MSEI Symbol NOTLISTED
ISIN INE061F01013
Name of company Fortis Healthcare Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 05-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 29-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Healthcare
Start date and time of board meeting 05-11-2026   11:45:00
End date and time of board meeting 05-11-2026   18:05:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 13-02-2026
Indicate Company website link for updated RPT policy of the Company https://www.fortishealthcare.com/investor/policies%20&%20code/policy%20on%20related%20party%20transactions
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no default on loans and Debt securities incurred during the period under review



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 51,941.00 1,00,886.00
Other income 9,150.00 11,042.00
Total income 61,091.00 1,11,928.00
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 10,925.00 22,646.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 749.00 230.00
(d) Employee benefit expense 7,771.00 15,363.00
(e) Finance costs 4,471.00 9,157.00
(f) Depreciation, depletion and amortisation expense 3,094.00 6,092.00
(f) Other Expenses
1 Hospital service fee expense 1,480.00 2,888.00
2 Professional and consultation fees to doctors 10,379.00 20,345.00
3 Other expenses 8,337.00 16,721.00
Total other expenses 20,196.00 39,954.00
Total expenses 47,206.00 93,442.00
3 Total profit before exceptional items and tax 13,885.00 18,486.00
4 Exceptional items 706.00 2,036.00
5 Total profit before tax 14,591.00 20,522.00
6 Tax expense
7 Current tax 1,183.00 2,000.00
8 Deferred tax 417.00 753.00
9 Total tax expenses 1,600.00 2,753.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 12,991.00 17,769.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 12,991.00 17,769.00
17 Other comprehensive income net of taxes 151.00 151.00
18 Total Comprehensive Income for the period 13,142.00 17,920.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 75,496.00 75,496.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.72 2.35
Diluted earnings (loss) per share from continuing operations 1.72 2.35
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.72 2.35
Diluted earnings (loss) per share from continuing and discontinued operations 1.72 2.35
24 Debt equity ratio 0.2100 0.2100
25 Debt service coverage ratio 2.1200 1.3900
26 Interest service coverage ratio 4.800 3.6800
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1,04,151.00
Capital work-in-progress 9,740.00
Investment property 0.00
Goodwill 2,722.00
Other intangible assets 20,321.00
Intangible assets under development 4.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 10,09,186.00
Trade receivables, non-current 0.00
Loans, non-current 2,333.00
Other non-current financial assets
1 Other non-current financial assets 172.00
Total of other non-current financial assets 172.00
Total non-current financial assets 10,11,691.00
Deferred tax assets (net) 0.00
Other non-current assets
1 Other non-current assets 282.00
2 Non-current tax assets (net) 16,831.00
Total of other non-current assets 17,113.00
Total non-current assets 11,65,742.00
2 Current assets
Inventories 1,911.00
Current financial asset
Current investments 0.00
Trade receivables, current 30,794.00
Cash and cash equivalents 868.00
Bank balance other than cash and cash equivalents 6,296.00
Loans, current 0.00
Other current financial assets
Total of other current financial assets 8,078.00
Total current financial assets 46,036.00
Current tax assets (net) 0.00
Other current assets
1 Other current assets 908.00
Total of other current assets 908.00
Total current assets 48,855.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 12,14,597.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 75,496.00
Other equity 8,64,883.00
Total equity attributable to owners of parent 9,40,379.00
Non controlling interest
Total equity 9,40,379.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1,62,682.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
Total of other non-current financial liabilities
Total non-current financial liabilities 1,62,682.00
Provisions, non-current 4,864.00
Deferred tax liabilities (net) 1,831.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 1,69,377.00
Current liabilities
Current financial liabilities
Borrowings, current 31,814.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 1,016.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 50,414.00
Total Trade payable 51,430.00
Other current financial liabilities
1 Other financial liabilities 16,045.00
Total of other current financial liabilities 16,045.00
Total current financial liabilities 99,289.00
Other current liabilities 3,112.00
1 Other current liabilities 3,112.00
Total of other current liabilities 3,112.00
Provisions, current 2,440.00
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 1,04,841.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 2,74,218.00
Total equity and liabilites 12,14,597.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss 202.00 202.00
Total Amount of items that will not be reclassified to profit and loss 202.00 202.00
2 Income tax relating to items that will not be reclassified to profit or loss 51.00 51.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 151.00 151.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 20,522.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 9,157.00
Adjustments for decrease (increase) in inventories 230.00
Adjustments for decrease (increase) in trade receivables, current (2,007.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (193.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current (10.00)
Adjustments for other financial assets, current (5,823.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 2,200.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (572.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 6,092.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 80.00
Adjustments for provisions, non-current 287.00
Adjustments for other financial liabilities, current (1,157.00)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 7,570.00
Adjustments for interest income 3,469.00
Adjustments for share-based payments 1,294.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 10.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (966.00)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (2,417.00)
Net cash flows from (used in) operations 18,105.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,198.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 16,907.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 25.00
Purchase of property, plant and equipment 5,677.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 7,570.00
Interest received 7,074.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (3,658.00)
Net cash flows from (used in) investing activities 5,334.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 6,561.00
Repayments of borrowings 17,894.00
Payments of lease liabilities 3,271.00
Dividends paid 7,558.00
Interest paid 1,878.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (24,040.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (1,799.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (1,799.00)
Cash and cash equivalents cash flow statement at beginning of period (577.00)
Cash and cash equivalents cash flow statement at end of period (2,376.00)





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Agilus Diagnostics Limited Agilus Diagnostics Nepal Private Limited (Formerly known as SRL Diagnostic (Nepal) Private limited) Joint venture company Any other transaction Investments (at net book value) 0.00 Nil 0.00 278.77 282.04
2 Agilus Diagnostics Limited Agilus Diagnostics Nepal Private Limited (Formerly known as SRL Diagnostic (Nepal) Private limited) Joint venture company Sale of goods or services 430.71 Nil 184.81 582.97 528.21
3 Agilus Diagnostics Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Sale of goods or services 64.34 Nil 36.18 354.74 338.15
4 Agilus Diagnostics Limited Gleneagles Healthcare India Pvt Limited Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Sale of goods or services 591.36 Nil 313.05 151.94 131.79
5 Agilus Diagnostics Limited Lanka Hospitals Diagnostics (Pvt) Ltd Associate Company Any other transaction Sale of goods or services 0.00 Nil 0.00 0.00 0.00
6 Agilus Diagnostics Limited Agilus Diagnostics Nepal Private Limited (Formerly known as SRL Diagnostic (Nepal) Private limited) Joint venture company Any other transaction Expense incurred on behalf of company by 26.68 Nil 10.02 80.28 90.30
7 Agilus Diagnostics Limited Ms. Suvalaxmi Chakrabarty Independent Director Any other transaction Director Sitting fees 15.00 Nil 9.00 0.00 0.00
8 Agilus Diagnostics Limited Lanka Hospitals Diagnostics (Pvt) Ltd Associate Company Loan 0.00 Nil 0.00 3.97 3.97
9 Agilus Diagnostics Limited Bharat Certis Agriscience Limited (Formerly known as Bharat Insecticides Limited) Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Trade Receivables 0.00 Nil 0.00 0.31 0.31
10 Agilus Diagnostics Limited Lanka Hospitals Diagnostics (Pvt) Ltd Associate Company Any other transaction Trade Receivables 0.00 Nil 0.00 0.00 0.00
11 Agilus Diagnostics Limited Centre for Digestive and Kidney Diseases (India) Private Limited Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Trade Receivables 0.00 Nil 0.00 0.12 0.12
12 Agilus Diagnostics Limited Mr. Indrajit Banerjee Independent Director Any other transaction Director Sitting Fees 15.00 Nil 8.00 0.00 0.00
13 Agilus Diagnostics Limited Agilus Diagnostics Nepal Private Limited (Formerly known as SRL Diagnostic (Nepal) Private limited) Joint venture company Any other transaction Gross Investments (net of sale proceeds) 0.00 Nil 0.00 150.00 150.00
14 Agilus Diagnostics Limited Premier Integrated Labs Sdn Bhd Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Sale of goods or services 8.14 Nil 8.14 2.37 2.95
15 Agilus Diagnostics Limited Lanka Hospitals Diagnostics (Pvt) Ltd Associate Company Any other transaction Advance from customers 0.00 Nil 0.00 6.09 6.09
16 Agilus Diagnostics Limited Premier Integrated Labs Sdn Bhd Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Expense incurred on behalf of company by 4.72 Nil 1.45 0.00 0.00
17 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Expenses incurred by the company on behalf 0.00 Nil 0.00 0.00 0.00
18 Escorts Heart Institute and Research Centre Limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 50.00 Nil 0.00 36.25 36.25
19 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Sale of goods or services 45.00 Nil 2.23 190.70 138.22
20 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Transfer of employee benefit liability to company from 0.00 Nil 0.00 0.00 0.00
21 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Hospital services given to group employees of 0.00 Nil 0.00 0.00 0.00
22 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Hospital services taken for employees from 15.00 Nil 0.65 0.00 0.00
23 Fortis Global Healthcare (Mauritius) Limited Mauritius International Trust Company Limited Enterprises significantly influenced by KMP and their relatives Any other transaction Legal and Professional fees 9.10 Nil 5.71 5.59 12.45
24 Fortis Healthcare International Limited RHT Health Trust Associate Company Any other transaction Gross Investments (net of sale proceeds) 0.00 Nil 0.00 54,991.49 54,991.49
25 Fortis Health management limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0.00 Nil 0.00 0.00 0.00
26 Fortis Healthcare International Limited Mauritius International Trust Company Limited Enterprises significantly influenced by KMP and their relatives Any other transaction Legal and Professional fees 9.10 Nil 5.71 0.00 7.83
27 Fortis Healthcare Limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0.00 Nil 0.00 16.22 0.00
28 Fortis Healthcare Limited Dr. Ashutosh Raghuvanshi Managing Director and Chief Executive Officer Any other transaction Remuneration 1,200.00 Nil 743.09 0.00 0.00
29 Fortis Healthcare Limited Mr. Vivek Kumar Goyal Chief Financial Officer Any other transaction Remuneration 500.00 Nil 380.09 0.00 0.00
30 Fortis Healthcare Limited Mr. satyendra chauhan Company Secretary Any other transaction Remuneration 403.00 Nil 126.91 0.00 0.00
31 Fortis Healthcare Limited Mr. Indrajit Banerjee Independent Director Any other transaction Remuneration 86.73 Nil 43.37 0.00 0.00
32 Fortis Healthcare Limited Ms. Suvalaxmi Chakrabarty Independent Director Any other transaction Remuneration 86.73 Nil 43.37 0.00 0.00
33 Fortis Healthcare Limited Ms. Shailaja Chandra Independent Director Any other transaction Remuneration 0.00 Nil 0.00 0.00 0.00
34 Fortis Healthcare Limited Mr. Indrajit Banerjee Independent Director Any other transaction Director Sitting Fees 44.84 Nil 17.70 0.00 0.00
35 Fortis Healthcare Limited Ms. Suvalaxmi Chakrabarty Independent Director Any other transaction Director Sitting Fees 35.40 Nil 14.16 0.00 0.00
36 Fortis Healthcare Limited Ms. Shailaja Chandra Independent Director Any other transaction Director Sitting Fees 0.00 Nil 0.00 0.00 0.00
37 Fortis Healthcare Limited Mr. Dilip Kadambi (Paid to Northern TK Venture Pte Ltd) Non-Executive Non-Independent Director Any other transaction Director Sitting Fees 17.70 Nil 1.18 0.00 0.00
38 Fortis Healthcare Limited Ashok Pandit Non-Executive Non-Independent Director Any other transaction Director Sitting Fees 36.58 Nil 7.08 0.00 0.00
39 Fortis Healthcare Limited Mitsui and Co. Ltd. (Mr.Tomo Nagahiro) Additional Director Any other transaction Director Sitting Fees 0.00 Nil 0.00 0.00 0.00
40 Fortis Healthcare Limited Mr. Prem Kumar Nair Non-Executive Non-Independent Director Any other transaction Director Sitting Fees 20.06 Nil 4.72 0.00 0.00
41 Fortis Healthcare Limited Dr. Ashutosh Raghuvanshi Managing Director and Chief Executive Officer Any other transaction Reimbursement of expenses 40.00 Nil 16.88 0.00 0.00
42 Fortis Healthcare Limited Mr. Indrajit Banerjee Independent Director Any other transaction Reimbursement of expenses 5.00 Nil 0.35 0.00 0.00
43 Fortis Healthcare Limited Ms. Shailaja Chandra Independent Director Any other transaction Reimbursement of expenses 0.00 Nil 0.00 0.00 0.00
44 Fortis Healthcare Limited Ms. Suvalaxmi Chakrabarty Independent Director Any other transaction Reimbursement of expenses 8.00 Nil 1.43 0.00 0.00
45 Fortis Healthcare Limited Mr. Dilip Kadambi (Paid to Northern TK Venture Pte Ltd) Non-Executive Non-Independent Director Any other transaction Reimbursement of expenses 0.00 Nil 0.00 0.00 0.00
46 Fortis Healthcare Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Other balance recoverable 0.00 Nil 0.00 28.39 0.00
47 Fortis Healthcare Limited Mr. Leo Puri Independent Director Any other transaction Remuneration 230.10 Nil 115.05 0.00 0.00
48 Fortis Healthcare Limited Mr. Leo Puri Independent Director Any other transaction Reimbursement of expenses 20.00 Nil 8.98 0.00 0.00
49 Fortis Healthcare Limited Mr. Prem Kumar Nair Independent Director Any other transaction Reimbursement of expenses 15.00 Nil 0.67 0.00 0.00
50 Fortis Healthcare Limited Mr. Leo Puri Independent Director Any other transaction Director Sitting fees 20.06 Nil 8.26 0.00 0.00
51 Fortis Healthcare Limited Fortis CSR Foundation Joint venture company Any other transaction Gross Investments 0.00 Nil 0.00 5.00 5.00
52 Fortis Healthcare Limited Gleneagles Healthcare India Pvt Limited Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Sale of goods or services 4,221.04 Nil 1,092.75 203.13 186.40
53 Fortis Healthcare Limited Mr. LIM TSIN LIN Independent Director Any other transaction Director Sitting fees 0.00 Nil 0.00 0.00 0.00
54 Fortis Healthcare Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Brand license income 50.00 Nil 27.61 0.00 0.00
55 Fortis Healthcare Limited Dr. Ashutosh Raghuvanshi Managing Director and Chief Executive Officer Any other transaction Sale of Property, Plant and Equipment 0.00 Nil 0.00 0.00 0.00
56 Fortis Healthcare Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Transfer of employee benefit liability by company to 0.00 Nil 0.00 0.00 0.00
57 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Sale of goods or services 0.00 Nil 0.00 0.00 0.00
58 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Consultation fees to doctors 0.00 Nil 0.00 0.00 0.00
59 Fortis Hospitals Limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0.00 Nil 0.00 40.06 64.06
60 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Gross Investments 0.00 Nil 0.00 1,922.85 1,922.85
61 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Provision for Investment 0.00 Nil 0.00 1,922.85 1,922.85
62 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Other Balance Recoverable 0.00 Nil 0.00 0.00 0.00
63 Fortis Hospitals Limited Fortis Cauvery Joint Venture of Subsidiary Any other transaction Other Balance Recoverable 0.00 Nil 0.00 13.25 13.25
64 Fortis Hospitals Limited Fortis Cauvery Joint Venture of Subsidiary Any other transaction Provision for Doubtful Receivable 0.00 Nil 0.00 13.25 13.25
65 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Interest Accrued 50.00 Nil 50.00 0.00 0.00
66 Fortis Hospitals Limited Fortis CSR Foundation Joint venture company Any other transaction Sale of goods or services 0.00 Nil 0.00 0.00 0.00
67 Fortis Healthcare Limited Keith Hsiu Chin Lim Independent Director Any other transaction Director Sitting fees 14.16 Nil 2.36 0.00 0.00
68 Fortis Hospitals Limited Ms. Shailaja Chandra Independent Director Any other transaction Director Sitting fees 0.00 Nil 0.00 0.00 0.00
69 Fortis Hospotel Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Consultation fees to doctors 100.00 Nil 50.88 0.00 0.00
70 Fortis Hospotel Limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0.00 Nil 0.00 18.26 15.07
71 Fortis Hospotel Limited Fortis CSR Foundation Joint venture company Any other transaction Sale of goods or services 0.00 Nil 0.00 0.00 0.00
72 Fortis Hospotel Limited Mr. Indrajit Banerjee Independent Director Any other transaction Director Sitting fees 2.40 Nil 0.59 0.00 0.00
73 Fortis Hospotel Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Transfer of employee benefit liability to company from 0.00 Nil 0.00 0.00 0.00
74 Fortis Malar Hospitals Limited Ms. Shailaja Chandra Independent Director Any other transaction Director Sitting fees 9.00 Nil 3.50 0.00 0.00
75 Fortis Malar Hospitals Limited Ms. Suvalaxmi Chakrabarty Independent Director Any other transaction Director Sitting fees 9.00 Nil 2.50 0.00 0.00
76 Hiranandani healthcare private limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0.00 Nil 0.00 0.00 0.00
77 Hiranandani healthcare private limited Centre for Digestive and Kidney Diseases (India) Private Limited Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Consultation fees to doctors 90.00 Nil 3.62 8.40 0.00
78 International Hospital Limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0.00 Nil 0.00 98.55 11.73
79 International Hospital Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Sale of goods or services 0.00 Nil 0.00 0.00 0.00
80 International Hospital Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Expenses incurred by the company on behalf 0.00 Nil 0.00 0.00 0.00
81 International Hospital Limited Ms. Shailaja Chandra Independent Director Any other transaction Director Sitting Fees 0.00 Nil 0.00 0.00 0.00
82 Fortis Asia Healthcare Pte Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Gross Investments (net of sale proceeds) 0.00 Nil 0.00 19,762.82 19,762.82
83 Fortis Asia Healthcare Pte Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Dividend Income 0.00 Nil 180.29 0.00 0.00
84 Fortis Asia Healthcare Pte Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Provision for Investment 0.00 Nil 0.00 6,374.38 5,123.85
85 Fortis Asia Healthcare Pte Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Impairment on investment 0.00 Nil 1,250.54 0.00 0.00
86 Fortis Asia Healthcare Pte Limited RHT Health Trust Associate Company Any other transaction Gross Investments (net of sale proceeds) 0.00 Nil 0.00 5,862.26 5,862.26
87 Fortis Asia Healthcare Pte Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Investments (at net book value) 0.00 Nil 0.00 19,155.53 21,396.90
88 Fortis Asia Healthcare Pte Limited RHT Health Trust Associate Company Any other transaction Investments (at net book value) 0.00 Nil 0.00 3,080.21 3,170.78
89 Religare Health Trust Trustee Manager RHT Health Trust Associate Company Any other transaction Sale of goods or services 60.00 Nil 33.46 0.00 0.00
90 Fortis Healthcare Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction ESOP Expense 66.72 Nil 31.32 0.00 31.32
91 International Hospital Limited Mr. Indrajit Banerjee Independent Director Any other transaction Director Sitting fees 2.40 Nil 0.89 0.00 0.00
92 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Reimbursement of expenses 5.00 Nil 0.52 0.00 0.00
Total value of transaction during the reporting period 4,849.07